Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
1
Di ag nosis of leptospirosis a nd chara cte rization of Leptospira
Rudy Hartskeer l
Amsterda m, The Netherla nds www.kit.nl
Leptospirosis is globally emerging but still severely underestimated
>350,000 severe cases annually (ILS and WHO-LERG)
Reasons 1
•Mild to severe and uncharacteristic protean manifestations•Zoonosis with a complex and dynamic epidemiology
•Falls into (or rather between) several categories: zoonosis,
vector/rodent-borne, water-borne, food-borne, poverty, occupational disease
Reasons 2
•Difficult diagnosis (not recognised)•Cases not reported (no notification)
•Unawareness (Ignored)
Amsterda m, The Netherla nds www.kit.nl
Combatting leptospirosis
Increased awareness
Prevention and contro l measures (tay lor made)
Amsterda m, The Netherla nds www.kit.nl
Increased awareness
•Improved diagnosis; Diagnostic tests
•Notification and surve il lance
•Education, courses, meetings•International Leptospirosis Society (ILS)
Amsterda m, The Netherla nds www.kit.nl
Conventional testsConventional tests: Isolation, DFM, MAT, ELISA, IFAT,
IHA, MSAT etc.
Many drawbacks: slow, unrel iable, low detection
threshold, difficult to standardize, requi re wel l-trained personne l and/or expensive media/equipment
Amsterda m, The Netherla nds www.kit.nl
Rapid diagnosis: point-of-care tests•Easy•Simple•Reliable•Quick•Stable•Affordable
Negative Positive
Latex agglutination1 min
Lateral flow test10-15 min
2
Amsterda m, The Netherla nds www.kit.nl
LEPTO lateral flow assay compared with MAT and ELISAin the Netherlands
<10 DPO >10 DPO
Sens % Spec % Sens % Spec %
MAT 69 99 94 99
ELISA 57 96 84 99
LeptoTek LFA
66 93 81 96
Zephyr LFA 49 100 83 98
Amsterda m, The Netherla nds www.kit.nl
Drawbacks•Confirmation by MAT
•Based on serology: too la te for early diagnosis
•Differences in diagnostic accuracy in di fferent endemic backgrounds: Local evaluation is needed
•Based on crude antigen?
Amsterda m, The Netherla nds www.kit.nl
Rapid vs early diagnosis
Rapid diagnosis with po int-of-care test →
Rapid diagnosis is NOT equa l to ear ly diagnosis →
Early diagnosis detects leptospires or leptospira l products at an early acute phase of disease
Amsterda m, The Netherla nds www.kit.nl
‘Early’ tests: Detecting leptospires or products
• DFM
• Capture ELISA
• Observation by staining thin sections
• Immunological detection
• PCR detection of DNA
Amsterda m, The Netherla nds www.kit.nl
Detect leptospires or their productsDFM•Sensitiv ity of 104 leptospires per ml•Protein fibers mimic leptospires, low specificity: NOT recommended
Antigen capture tests•sensi tivi ty of about 105 leptospires (equivalents) per ml•Improved detection assays not to be expected within years to come
Staining of thin sections• silve r staining• immunohistochemistry
Useful for , e.g., kidney carriers, but limited diagnostic use
Immunological detection• immunofluorescence• radioimmunoassay
Sensitiv ity in the order of 105 per ml
Amsterda m, The Netherla nds www.kit.nl
Detect leptospires or their products: PCR
Levels of Specificity•Genus•Species•Serovar
Choice of primers
3
Amsterda m, The Netherla nds www.kit.nl
Some approaches that have been used
Reistetter, 2006. ompL1 gene – differentiates 6 spec ies
Woo et al., 1997. 23S rRNA gene – differentiates L.biflexa vs L.interrogans
Brown et al., 1997. AP-PCR – roughly at serovar level
Zuerner et al., 1995. IS1533 – Leptospira spec ific but not enough strains tes ted to draw conclusions about spec ies or serovar
Merien et al., 1992 (and many others). 16S rRNA – genus or
spec ies level depending on primers
In real-time PCR: multiplex reactions (Taqman) of differences in Tm (SYBR Green)
Amsterda m, The Netherla nds www.kit.nl
Detect leptospires or their productsConv ention al PCR
Amsterda m, The Netherla nds www.kit.nl
PCR Phases in Log view
Amsterda m, The Netherla nds www.kit.nl
1 2 3 4 5 6 7 8 9 10 11 12 13 14
15 16
Conventional PCR
No Le ptospira strain 1 H6 10- 3
2 H6 10- 4
3 H6 10- 5
4 H6 10- 6
5 H6 10- 7
6 lely 10- 2 7 1342k 1 0-2
8 1161 1 0-2
9 Cellod 10- 2
10 1051 1 0-3
11 A23 10- 2 12 I CF 10- 3
13 P at oc N.P
14 100bp marker
15 BUT6 N.P 16 H20 N.T
– Agarose gel electrophoresis- Hybridisation(Nested primers)
Amsterda m, The Netherla nds www.kit.nl
Primer set SecY II/IV
Primer set Gf3G1a
Probes:
DIGprobe-1DIGprobe-2
G195-28
Conventional PCR: Southern Blotting
Amsterda m, The Netherla nds www.kit.nl
Conventional PCRHow does PCR perform?
Brown et al ., 1995. Blood/urine.PCR 62% pos, culture 48% pos.
Mer ien et al ., 1995. PCR vs MAT in 200 cases.14/14 later seroconverted. Another 13 positive?
Yersin et al ., 1999. PCR vs MAT in 90 cases.MAT 75/90 pos, PCR pos 33/75 (44%)
15 MAT neg were PCR pos?
Zhang et al ., 1993. SerumPCR 75% pos but controles 15% pos
There are many more papers in the li terature which describe some use of PCR for diagnosis
4
Amsterda m, The Netherla nds www.kit.nl
Conventional PCR
• Conventional PCR can be very sensitive
• Contamination leading to false positives is a real problem
• Standard PCR precautions are mandatory
• Separate “clean” rooms for specimen reception etc. etc.
Amsterda m, The Netherla nds www.kit.nl
Time consuming
Low diagnostic sensitivity
Size-based discrimination (without hybridization)
Non–Automated
Ethidium bromide
Complicated quantification.
Further limitations of End-Point
(conventional) PCR
Amsterda m, The Netherla nds www.kit.nl
Detect leptospires or their productsReal-time PCR
Amsterda m, The Netherla nds www.kit.nl
Amsterda m, The Netherla nds www.kit.nl
Real-Time PCR Chemistries
Hydrolysis probes
• Molecular beacons/TaqMan Probes
DNA-binding agents
• SYBR green
Amsterda m, The Netherla nds www.kit.nl
TaqMan probe
5’ exonuclease activity of the enzyme cleaves the probe
5
Amsterda m, The Netherla nds www.kit.nl
PCR
Unbound SYBR Green1
Bound SYBR Green1
SYBR Green Dye
Amsterda m, The Netherla nds www.kit.nl
AdvantagesLower initial costMelt curve analysisSimple assay design
Disadvantages• Extensive optimisation• Normally used in singleplex reactions
(molecular beacons: high specificity by specific probe and multiplex reactions possible)
SYBR Green PCR
Amsterda m, The Netherla nds www.kit.nl
Real-time PCRSmythe et al., 2002. 23S rRNA – Taqman PCR.
Quantitative and improved specificity.Detection threshold 2-10 leptospires (depending on sample type). Sera, Useful
Pa lanaippan et al., 2005. lig-based Taqman PCR.
Detection threshold 6 leptospires.
Mer ien et al., 2005. LAO322-based SYBR Green PCR. Detection threshold 50 leptospires/ml.Sens 49% (25/51 cases).
Levett et al., 2005. lipL32-based SYBR Green PCR.Detection threshold 1-10 leptospires (depending on sample type).
Stoddard et al., 2009. lipL32-based Taqman PCR.
LOD about 10 copies
Amsterda m, The Netherla nds www.kit.nl
Real-time PCRReal-time PCR validations; culture as gold standard
•Slack et al., 2007. Taqman rrl- adapted• Analytical sensitivity: 10 copies• 236 samples with 28 culture positives.• Clinical sensitivity 96.4% and specificity 99.5%
•Ahmed et al., 2009. secY – adapted SYBR Green• Analytical sensitivity: 1 – 30 copies, depending on sample type and ‘heterologous’ primer annealing• 114 samples with 12 culture positives• Clinical sensitivity 92% (100% till day 4) and specificity 94%.
•Thaipadunpanit et al., 2011. Compares Taqman rrs with Taqman lipL32-based PCR. Real time PCR contributes to individual patient care
Amsterda m, The Netherla nds www.kit.nl
Real-time PCR
• Apart from early diagnosis
• Quick and quantitative
• One tube system; less contamination prone
Useful
Amsterda m, The Netherla nds www.kit.nl
Conclusion
• Conventional tests many drawbacks.
•Tests based on serology can be rapid but confirm leptospirosis afterwards . HOWEVER, contribute as such on increasing the awareness.
•Real-time PCR is a promising method for early confirmation of clinical diagnosis when antibiotic treatment is most effective (first 5 days of illness).
6
Amsterda m, The Netherla nds www.kit.nl
Characterization of Leptospira
Amsterda m, The Netherla nds www.kit.nl
Why typing of Leptospira?
• Source identification (same strain in patient and
suspected animal source) → control and intervention
• Immunization; current vaccines (human and animals) give
serovar specific protection – knowledge of local serovars needed for vaccine deve lopment and/or application
• Diagnosis, optimal local MAT panel
Amsterda m, The Netherla nds www.kit.nl
Th e epid emiology of leptospirosis is c omplex and dynamic: nearly 300 serovars
Generally adapted to a certain host• More than one serovar adapted to one host
• Pigs: Pomona, Tarrasovi, Bratislava• Cows: Hardjo, Pomona
• One serovar adapted to several hosts• Bratislava: pigs, hedgehogs• Grippotyphosa: common voles, hares
Serovars may adapt to new hosts
Introduction of new animals imply introduction of (new) Leptospira serovars
• Climatologic change• Landuse change (deforestation, urbanization)
Amsterda m, The Netherla nds www.kit.nl
Continuous surveillance is important!
Amsterda m, The Netherla nds www.kit.nl
Pathogenic and saprophytic leptospires
Saprophytic leptospires live in the environment
Pathogenic leptospires live in the kidneys of host animals
Amsterda m, The Netherla nds www.kit.nl
7
Amsterda m, The Netherla nds www.kit.nl
Survival in the environment
Pathogenic leptospires are excreted with the
urine into the environment
Survival for months if conditions are
favourable•Humid
•Moderate to warm (≤ 30oC)•Neutral to slightly alkaline (pH 6.5 – 8.5)
Amsterda m, The Netherla nds www.kit.nl
Amsterda m, The Netherla nds www.kit.nl
Picardeau et al., PLoS ONE 2008
Amsterda m, The Netherla nds www.kit.nl
Leptospira have to adapt to a wide variety of ‘environments’
• Wide var iety of leptospires; spatial and tempora l
differences
• Wide var iety of clinical manifestations
• Trends of serovars causing mild or severe disease
• Serovars associa ted to cer tain hosts: Identification of
infection source re lies on the determination of the same
leptospire in the patient and in the suspected source
Amsterda m, The Netherla nds www.kit.nl
Classification of Leptospira• 2 classification systems
• Based on serology (conventional)• Based on DNA composition/sequence
(recent)
• The two classification systems do not corre late
Amsterda m, The Netherla nds www.kit.nl
Leptospira; serological and molecular classification
• Serological classification; serovar is basic taxon• Serovar identified by specific agglutination features with rabbit antisera (CAAT)• >250 pathogenic serovars grouped into 25 serogroups• Typing requires cultured leptospires• Highest titers in MAT give at the best clues on infecting serogroups
• Molecular classification; species• 20 species, including 9 pathogenic• Several methods
• Requiring cultures – e.g. finger printing• Not requi ring cultures – e.g. sequencing of DNA fragments amplified in diagnostic PCR
8
Amsterda m, The Netherla nds www.kit.nl
Serological characterizationSerogrouping: MAT with rabbit anti-Leptospi ra re ference
seraTyping of serovars: MAT with panels of monoclonal
antibodies
Standard test for serovar character ization is Cross Agglutinin Absorption Test (CAAT); requi res reference
rabbit anti-Leptospi ra antisera and is tedious and labor ious
Amsterda m, The Netherla nds www.kit.nl
Molecular characterization
Amsterda m, The Netherla nds www.kit.nl
Conventional DNA-based classification m ethods
1. DNA hybridization conditions form the basis for species
determination (Brenner et al., 1999)2. REA, RAPD, LS-PCR
3. PFGE largely coincides with serovar status
Drawbacks• difficult to standardize• No (direct) digital data• Require cultures
International shipment of viable pathogens is di fficult and expensive: Not suitable in most settings
Amsterda m, The Netherla nds www.kit.nl
Novel molecular methods
•MLVA (Mul tiple- locus Variable number of tandem repeats (VNTR) Analysis; not genera lly applicable on a ll species (2 of 9
pathogenic spp.)
•(Fluorescent) Ampl ified Fragment Length Polymorphism (F)AFLP; applicable on any organism
•Typing arrays; need for identification of SNPs•(Mul tiLocus) Sequence Typing (MLST); need for conserved
sequences for ampl ification pr ior to sequencing
Amsterda m, The Netherla nds www.kit.nl
MLVA
Amplification of short sequence DNA repeats
Number and thus amplicon size strain specific
Need to know the repeats: currently restricted to L. interrogans and L. borgpetersenii
• Majed et a l., J Clin Microbio l. 2005;43:539.• Slack et al., ACMA 2006;4:10
• Na lem et al., PLoS ONE 2010;5:e12637
Amsterda m, The Netherla nds www.kit.nl
EcoRIMseI
AdaptersMseI & EcoRI
T4 DN A Liga se
Preselect ive Amplification(p rimers op po site to adapters)
Selective Amplification
(F luo ro ph ore labeled Pr imers withon e base extend ing ou t)
Elec trophoresis
Geno typing
Fluorescent Amplified Fragment Length Polymorphism
Genomic DNA
EcoRIMseI EcoRIMseI
9
Amsterda m, The Netherla nds www.kit.nl
FAFLP o f Leptosp iral strains
L.inte rrogansL. kirsc hneriL.noguchiiL. weilliL. borgpete rse niiL. santarosai
L. i nte rrogans
L. kirschn e ri
L. santarosai
L. b orgpe te rsen ii
L. n oguch ii
L. we il li
L. i nadai
L. meye ri
L. gen omosp e cie s 1
L. ale xand e riNalam et al., PLoS ONE 2010
Amsterda m, The Netherla nds www.kit.nl
Check-Points
multiplex ligase-amplification based typing
array
Amsterda m, The Netherla nds www.kit.nl
Pr obes position in the Ar ray Tube
B. Al ig nm en t c on trol .
H. Hyb rid iz ati on c on trol
A. In tern al c on trol
B H 1 2 3 5 6 7 B
8 9 10 11 12 13B 14 15 16 17 20 21 22 25 B
A A A H BB BB H B
B B
Check-Points multiplex ligase probe am plification (MLPA) based typing array
Ahmed et al., Infect Gen Evol, 2010
Amsterda m, The Netherla nds www.kit.nl
L.
inte
rro
agns
71
L.
inte
rro
ag
ns
3L
. in
ter
roa
gns
13
L.
inte
rro
agn
s 1
5L
. in
ter
roa
gns
82
L.
bor
g pe
ter
sen
ii 2
29
L. i
nte
rroa
gn
s 7
L. i
nte
rroa
gn
s 12
1L
. in
te r
roa
gns
12
4L
. in
ter
roa
gns
65
L.
inte
rro a
gn
s 1
19
L. in
te r
roa
gn
s 11
8L
. in
ter
roa
gns
12
0
L.
inte
rro a
gn
s 6
4
L . i
nter
roa
gn s
12
3
L.
int e
rro
a gn
s 8
L. i
n te
rroa
gns
10
L.
i nte
r ro
agn
s 1
22
L. i
nte r
roa
gns
43
L.
int e
rroa
gn
s 28
L. i
n ter
roa
gns
42
L.
inte
r roa
gn
s 32
L. i n
ter
roa g
ns
30
L.
inte
rroa
gns
31
L. in
t err
o ag
ns 2
L. in
ter
r oag
ns
17
L.
ki rsc
hn e
ri 1
47
L.
inte
r roa
gns
44
L . in
terr
oag
n s 4
5
L. in
te rr
o ag
ns 4
1
L. i
n te r
roag
ns 3
8
L.
i nte r
roag
ns
3 9
L . i n
te rro
a gn
s 14
L . i n
terro
agn
s 1 6
L . i n
terr o
agn
s 27
L. in
terr o
agn
s 34
L. in
terro
agn
s 6
L. in te
rroa
gns 4
L. i
n terro a
gns 2
5
L. i
n terro
ag n
s 11 5
L. i
n terro
a gn s
11 7
L. in
t er ro
agn s
114
L. i n
terr o
agns
18
L. in
terr o
a gns
2 1
L. in
terr oa
g ns 6
7
L. in
terroa
gns 7
4
L . i nt
er ro ag
n s 92
L. in t
e rr oag
n s 5
L . inte
rr oa g n
s 62
L . int e
r roagn
s 69
L. interr
oa gn s
66
L. in
terro a g
ns 68
L. in t
e r roa gn
s 70
L . inte
rroag n s
11 6
L. int er
rog an s 1
L . interro
a g n s 61
L. in t e
r roa gn s 8
0
L. inter
r oa g ns 81
L . inter ro
a gn s 1 3 0
L . i nt e rro a
g ns 131
L . interroa g n s
132
L. in ter ro
a gn s 13 3
L. i nt e rro a g
ns 12 9
L . interr oa g n s 1 2
5
L . interro ag n s 12 6
L . int er roa g ns 12
8
L. i nt er roa g ns 13 4
L. i nt e rro a g n s 11 1
L. i n terroa g n s 1 1
L . i n terro ag ns 91
L . interro ag n s 11 3
L . ki rsc hn e ri 15 4
L . interro ag n s 85L . interro ag n s 86L . in
terr o ag n s 89L . i n terr oa g n s 8 3L . i n terr o
a g n s 8 7L. i nt e rro a g n s 88L
. in ter ro a gns 20L . in te
r ro a gn s 26
L . interr o ag n s
1 9L .
i nt e rro ag n s 29L. int e
r ro a g ns 1 1 2
L . inter ro a gn
s 5 6L .
i nt e rr oa g n s
57
L. int er
ro a gns 5 8
L . inte rr o a
g n s 78
L. int er ro
a gn s 7 9
L . in te rr
o ag ns 9
L. i nt e
r ro agn s
7 7
L. in t
e rr oag n s
23
L . i nt er r
o a gn s 2
4
L . in te r
r oag ns
7 6
L. in te
r ro ag n
s 96
L . in te
rroa gn
s 10 7
L. in t
e rroa g
n s 1 0 4
L. i n
t er ro ag
n s 63
L. in
te rro a
gns 1 0
5
L. i
n terr o
a g ns 9
3
L. i
n terr o
ag ns
9 5
L . int e
r roag
n s 9 7
L . in te
r ro ag
n s 9
9
L. in te
rroa
gns 1
0 0
L. in t
e rroa
gns 1
0 1
L . in t
e rr oa
gns
103
L . i nt
e rr oa
gn s
106
L . i nt
erroa
g ns
1 08
L . int
err oa
gn s
109
L.
inter
r oag
n s 1
1 0
L. i
nter
roa g
n s 9
4
L. in
t er r
oagn
s 98
L. i
nterr
oag
n s 4
7
L. in
t err
oagn
s 5
2
L. in
t err
oagn
s 5 1
L.
me y
eri 2
70
L.
inte r
r oa
g ns
49
L. i
nte r
roag
ns
50
L. i n
terr
o ag n
s 5
5
L.
inte
r roa
gn s
53
L. i
n ter
roa g
ns
54
L . in
terr
oag
ns 2
2
L.
int e
rro a
gn s
37
L. i
nte r
roa
gns
36
L.
inte
rro
a gn
s 35
L. i
nte
r roa
gns
46
L. in
ter
roa
gns
60
L. i
nte
rroa
gns
12
L.
inte
rro
ag n
s 5
9
L. i
nte
rr oa
gn s
75
L.
in terr
oa g
ns
33
L. int
e rro
ag n
s 9
0
L. i
nte
rroa
gn
s 1
27
L.
bor
gpe
ter
sen
ii 21
6
L. k
ir sch
ner
i 138
L. k
irsc h
ne
ri 143
L.
kirs
chn
eri
150
L.
ki rsc
hn
eri 13
7
L. kirsc
hn
eri 16
0
L. kirs
chn
eri 1
63
L. k irs
chn
eri 1
59
L. kirs
chn
eri 1
56
L. ki
rschn
eri 15
7L
. kirsc
hne
ri 161
L. ki
rschn
er
i 162
L. ki
rschn
eri 15
5L
. kirsc
hne
ri 148
L. ki
rschn
eri 14
9L
. kirsch
ne
ri 151
L. kir
sch
ne
ri 152
L. kirsc
hn
eri 15
3L
. kirsc
hn
eri 13
5L
. kirsc
hne
ri 136
L. k
irsch
ne
ri 13
9L
. kirsch
ner
i 140
L. ki
rsch
ner
i 14
1L
. kirsch
ne
ri 142
L. kirsc
hn
eri 15
8
L.
kirschn
eri
145
L. kirs
chn
eri 14
6
L. kirsc
hne
ri 144L
. int
erro
ag
ns 4
0
L . n
ogu
chi
i 25
8
L.
in te
rroa
gns
48
L. n
og u
ch i
i 25
4
L.
nog
uch
ii 2
55
L. n
og
uch
ii 25
7
L. n
og u
ch i
i 25
1
L.
san
tar o
sai
1 76
L.
nog
u ch
i i 25
3
L. n
ogu
ch i
i 25
6
L. n
ogu
chii
25 2
L. n
ogu
c hii
250
L. i
n ad a
i 26
8
L. in
ad a
i 26
7
L. b
o rgp
eter
s en i
i 21 5
L. w
ei lli
260
L. w
ei lli
261
L. i
nterr
oagn
s 1 0
2
L. in
ter ro
agns
72
L. w
ei lli
266
L. w
ei lli
262
L. w
ei lli
263
L. w
eilli
2 65
L . w e
illi 2 6
4
L. b
or gp e
t er se
n ii 22
4
L. b
or gp e
t er se
n ii 24
2
L. b or
gpe te
r se n
ii 24 3
L . bo
r g pe te
rsen i
i 241
L. b o
rgpe t
e rse n
i i 240
L . bo rg
p et er s
e nii 2
3 9
L . bo
r gpe te
rsen ii
2 44
L. bo
r gpe te
rseni i
2 45
L. bo rg
peter s
e nii 2 4
9
L . bo
rgpet er
s enii 2
12
L . bor gp
e terse
ni i 22 5
L. bo r
g pet er s
e n ii 23 3
L. bo
r gpe ter
s en ii 2 3 4
L . bor g
pe ter se n
ii 235
L. b o r
g p e te rse
ni i 2 36
L . bor g p
e ter se n ii 2
37
L. b o r
g p e terse ni i
23 8
L . bor g pe
t er se nii 246
L. bo r g
p e terse n ii 2
4 7
L. bo rgp et
e rse ni i 24 8
L . bo r gp e ter se
n ii 2 30L . b
o rgp e terse n ii 2
3 1L. bo rgp
et e rse ni i 2 3 2
L . bor g pe t er s
en ii 21 1L . b or g peter se n ii 20 9L .
bo r gp e terse n ii 2 10L. bo rgp e t
e rse n ii 22 2L. bo rgp e terse n ii 22 3L. bo rgp e ter
s e n ii 22 1L. bo rgp et e rse ni i 2 0 7L . bo rgp et e rse ni i 2 0 8
L . bo rgp et e rse ni i 2 2 6
L. bo rgp e terse ni i 2 2 8
L. bo rg p e ters e nii 21 3
L . we il li 25 9
L . bo r gp eters e n ii 2 20
L . bor gp e ter se n ii
2 17
L . b or g pet er se n ii 21
8
L. borg p et e rs e
ni i 2 1 9
L . inte r ro a gn
s 84
L. s an t a
r o sa i 171
L. b or g p
e t er s en ii 2 1 4
L . sa nta ro s a
i 1 7 5
L . san t ar
o sa i 16 5
L . sa nta ro s
ai 1 9 5
L . san ta r
os a i 19 6
L . s an ta ro
sa i 164
L. bo r
gp e te rs e n
ii 227
L . sa n ta
ro sai 2 0
5
L. s an
ta r os a i
2 0 6
L . sa n t
a ro sai 2
02
L. s a
nt ar o s
a i 20 4
L. s a
n ta ro s a
i 2 03
L . sa n
ta rosa
i 174
L. s
a ntar o
sa i 1 9 7
L. s a
n taro s
ai 177
L. s an
ta ro s a
i 178
L. s
a nta r
o sai 1
6 9
L. a
ll exan
d eri 2
7 1
L . s a
nt ar o
s ai 1 6
8
L . s a
ntaro
s ai 19
8
L. s an
taro s
ai 19
9
L. s
anta
ro sa i
170
L. s
anta r
o sa i
2 01
L. i
nt err o
agn
s 73
L . s a
n ta r
o sa i
1 92
L . s a
nta r
osa i
1 94
L . s a
n ta r
o sa i
1 89
L . s a
nta r
o sa i
190
L . sa
nta r
o sa i
191
L. sa
nta
rosa
i 16 6
L. s
a nta
rosa
i 17
3
L. s
a nt a
rosa
i 19
3
L . s
anta
r osa
i 1 6
7
L. s
an ta
ros
ai 2
00
L. s
an t
a ros
ai 1
79
L.
san
taro
s ai 1
84
L.
san
taro
sai
183
L. s
anta
ros
a i 1
8 0
L. s
an t
aros
ai 1
82
L.
san
tar o
sai
181
L.
san
taro
sa
i 18
5
L. s
an t
aro
sai
186
L.
san
tar o
sa
i 17
2L
. in
ad a
i 26
9
L. s
an
taro
sai
18
7
L.
sa n
tar
osa
i 18
8
L.interrogans
L. kirsc hneri
L.noguchiiL. weilli
L. borgpeterseniiL. santarosai
MLST of Leptosp iral strains
Ahmed et al., ACMA 2006; Nalam et al., PLoS ONE 2010Thaipa dunpanit et al., PLoS NTD 2007
Amsterda m, The Netherla nds www.kit.nl
Summary•Tests based on serology confirm leptospirosis afterwards BUT contribute to increased awareness.
•Culturing leptospires important for epidemiology and for improved MAT panels
•Real-time PCR is promissing for early confirmation of clinical diagnosis when antibiotic treatment is most effective (first 5 days of illness).
•Dawn of isothermal amplification-LAMP?(first report on NASBA in 1994-Colenbrander et al., Ned. Tijdschr Geneeskd).
•CAAT limited to few reference centres
•Conventional molecular typing method not suitable for wide use
•Novel molecular typing methods need only DNA and/or generate digital data for onl ine comparison
Amsterda m, The Netherla nds www.kit.nl
Thank you